• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Distributed research: a new paradigm for undergraduate research and global problem solving?
  Bruce Parkinson Energy Environ. Sci., 2010,3, 509-511
• 3. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Fe3O4 nanosphere@microporous organic networks: enhanced anode performances in lithium ion batteries through carbonization?
  Byungho Lim,Jaewon Jin,Jin Yoo,Seung Yong Han,Kyeongyeol Kim,Sungah Kang,Nojin Park,Sang Moon Lee,Hae Jin Kim,Seung Uk Son Chem. Commun., 2014,50, 7723-7726

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Trifluoromethylbenzenes

Recent Advances in the Application of 2-Bromo-3,5-bis(trifluoromethyl)benzoic Acid (CAS: 505084-54-8) in Chemical Biology and Pharmaceutical Research

2-Bromo-3,5-bis(trifluoromethyl)benzoic acid (CAS: 505084-54-8) is a highly versatile chemical intermediate that has garnered significant attention in recent years due to its unique structural and electronic properties. This compound, characterized by the presence of bromine and trifluoromethyl groups on a benzoic acid scaffold, has found extensive applications in medicinal chemistry, agrochemical development, and materials science. Recent studies have highlighted its potential as a key building block in the synthesis of bioactive molecules, particularly in the design of enzyme inhibitors and receptor modulators.

One of the most notable applications of 2-Bromo-3,5-bis(trifluoromethyl)benzoic acid is its role in the development of kinase inhibitors. Kinases are critical targets in cancer therapy, and the trifluoromethyl groups in this compound enhance its binding affinity to ATP-binding sites. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited potent inhibitory activity against EGFR and VEGFR2 kinases, with IC50 values in the low nanomolar range. The study also highlighted the compound's favorable pharmacokinetic properties, making it a promising candidate for further preclinical development.

In addition to its therapeutic potential, 2-Bromo-3,5-bis(trifluoromethyl)benzoic acid has been employed in the synthesis of advanced materials. Researchers have utilized its electron-withdrawing properties to design novel organic semiconductors and liquid crystals. A recent publication in Advanced Materials (2024) described the use of this compound as a precursor for the development of high-performance organic field-effect transistors (OFETs), showcasing its versatility beyond pharmaceutical applications.

The synthetic utility of 2-Bromo-3,5-bis(trifluoromethyl)benzoic acid has also been explored in agrochemical research. Its halogenated and fluorinated motifs are particularly valuable in the design of herbicides and fungicides. A 2023 study in Pest Management Science reported the synthesis of a series of novel fungicides derived from this compound, which exhibited broad-spectrum activity against phytopathogenic fungi while demonstrating low toxicity to non-target organisms.

Despite its promising applications, challenges remain in the large-scale production and purification of 2-Bromo-3,5-bis(trifluoromethyl)benzoic acid. Recent advances in flow chemistry and continuous manufacturing have addressed some of these issues, as reported in Organic Process Research & Development (2024). These technological innovations have significantly improved the yield and purity of the compound, making it more accessible for industrial applications.

Looking ahead, the unique properties of 2-Bromo-3,5-bis(trifluoromethyl)benzoic acid (CAS: 505084-54-8) position it as a valuable tool in drug discovery and materials science. Ongoing research is exploring its potential in targeted drug delivery systems and as a scaffold for the development of covalent inhibitors. As synthetic methodologies continue to evolve, this compound is expected to play an increasingly important role in addressing complex challenges in chemical biology and pharmaceutical development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)